ADAPTIVE BIOTECHNOLOGIES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.75 USD | -5.50% |
|
-6.14% | -43.88% |
Chart calendar Adaptive Biotechnologies Corporation
481f47d4c6e803f105b922c1edcd.O78J0ja6EID6xb8hHGjZYGAFiGNn7YFUTFS3IkX5XcU.WNhujWXseNDCqclUU1-oNFFS0ScevO0xdDCCQSnMJ6ti9Xm-ZN1I0LOa9g~baaf4766ea1f76f76159c31695b48f50
Upcoming events on Adaptive Biotechnologies Corporation
Past events on Adaptive Biotechnologies Corporation
| 2024-04-02 04:30 pm | Business Update Call |
| 2024-03-04 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-14 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-14 04:06 pm | Q4 2023 Earnings Release |
| 2024-01-09 04:30 pm | JPMorgan Healthcare Conference |
| 2023-12-12 12:00 pm | American Society of Hematology Meeting - Abstract No - LBA-1 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 5029 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4359 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4715 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4747 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4407 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4847 |
| 2023-12-11 08:15 pm | American Society of Hematology Meeting - Abstract No - 1024 |
| 2023-12-11 07:45 pm | American Society of Hematology Meeting - Abstract No - 1028 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4671 |
| 2023-12-11 02:45 pm | American Society of Hematology Meeting - Abstract No - 738 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3257 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3777 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3380 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3385 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 85,1 82,6 3.01% | 98,4 94,8 3.77% | 154 153 0.69% | 185 185 0.16% | 170 173 -1.5% | 176 |
|
EBITDA Million USD | Released Forecast Spread | -57,5 -54,5 -5.41% | -120 -123 2.98% | -152 -160 5.29% | -122 -158 23.14% | -116 -120 3.05% | -116 |
|
EBIT Million USD | Released Forecast Spread | -78,4 -74,5 -5.23% | -153 -147 -4.09% | -209 -211 0.86% | -200 -202 0.96% | -227 -203 -11.79% | -190 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,6 -73,2 6.31% | -146 -142 -3.05% | -207 -208 0.36% | -200 -209 3.91% | -225 -204 -10.4% | -193 |
|
Net income Million USD | Released Forecast Spread | -69,6 -63,9 -8.9% | -146 -142 -3.19% | -207 -208 0.37% | -200 -209 4.42% | -225 -204 -10.36% | -193 |
|
EPS USD | Released Forecast Spread | -1,01 -0,53 -90.57% | -1,11 -1,08 -2.91% | -1,48 -1,49 0.8% | -1,40 -1,47 4.71% | -1,56 -1,41 -10.57% | -1,31 |
| Announcement Date | 26/02/20 | 24/02/21 | 15/02/22 | 14/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 37,9 36,9 2.93% | 38,6 37,7 2.41% | 43,7 41,8 4.43% | 47,8 48,0 -0.42% | 55,2 54,6 1.17% | 37,6 36,8 2.27% | 48,9 44,9 9% | 37,9 43,0 -11.74% | 45,8 48,5 -5.53% | 38,8 | 43,4 | 43,2 | 50,4 | 44,4 |
|
EBITDA Million USD | Released Forecast Spread | -44,9 -47,3 5.02% | -45,2 -47,1 4.21% | -33,1 -38,7 14.3% | -25,9 -39,2 34.04% | -19,6 -33,5 41.63% | -37,1 -37,2 0.14% | -24,8 -36,3 31.61% | -29,8 -28,3 -5.47% | -24,7 -24,2 -2.03% | -33,1 | -29,1 | -26,3 | -29,0 | -17,2 |
|
EBIT Million USD | Released Forecast Spread | -61,6 -66,4 7.29% | -63,1 -62,7 -0.6% | -52,5 -59,0 11.07% | -45,4 -53,1 14.42% | -39,2 -45,4 13.78% | -57,2 -53,0 -7.88% | -47,8 -48,1 0.51% | -51,0 -48,1 -5.91% | -71,1 -47,3 -50.27% | -51,0 | -47,3 | -45,6 | -46,2 | -46,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -61,4 -59,1 -3.78% | -62,8 -62,4 -0.72% | -52,1 -59,5 12.51% | -45,3 -54,9 17.49% | -40,2 -50,6 20.6% | -57,7 -60,5 4.61% | -47,8 -49,9 4.15% | -50,3 -47,5 -5.89% | -69,5 -47,7 -45.65% | -51,0 | -47,4 | -46,2 | -46,9 | -45,5 |
|
Net income Million USD | Released Forecast Spread | -61,4 -65,4 6% | -62,7 -61,8 -1.47% | -52,0 -58,7 11.34% | -45,3 -54,7 17.29% | -40,1 -49,4 18.76% | -57,7 -56,7 -1.79% | -47,8 -50,2 4.72% | -50,3 -48,5 -3.64% | -69,4 -47,7 -45.6% | -51,0 | -47,4 | -46,2 | -46,9 | -45,5 |
|
EPS USD | Released Forecast Spread | -0,43 -0,45 4.44% | -0,44 -0,44 0.01% | -0,37 -0,42 11.84% | -0,32 -0,38 16.04% | -0,28 -0,34 18.51% | -0,40 -0,38 -4.29% | -0,33 -0,34 3.62% | -0,35 -0,34 -4.22% | -0,48 -0,33 -47.26% | -0,35 | -0,33 | -0,32 | -0,32 | -0,32 |
| Announcement Date | 15/02/22 | 04/05/22 | 03/08/22 | 03/11/22 | 14/02/23 | 03/05/23 | 02/08/23 | 09/11/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Adaptive Biotechnologies Corporation
| 2024-04-12 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
| 2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
| 2024-02-22 04:05 pm | VERACYTE, INC.: Q4 2023 Earnings Release |
| 2024-02-22 04:05 pm | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
| 2024-02-22 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
| 2024-02-21 04:05 pm | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
| 2024-02-15 | SEEGENE, INC.: Q4 2023 Earnings Release |
| 2023-11-09 | SEEGENE, INC.: Q3 2023 Earnings Release |
| 2023-11-09 04:05 pm | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADPT Stock
- Calendar Adaptive Biotechnologies Corporation
